ASPH was detectable at early stage breast neoplasm, i.e., preinvasive DISC (ductal carcinoma in situ), substantially enhanced from IDC (invasive ductal carcinoma) to advanced/spontaneously metastatic breast cancer. This evidence concerns the gene ASPH and invasive ductal breast carcinoma.